Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
J Int Med Res ; 14(2): 110-4, 1986.
Article in English | MEDLINE | ID: mdl-2938995

ABSTRACT

Nine hundred and eleven patients were admitted to a multicentre trial with bacampicillin (Penglobe) in respiratory tract infections. Of these it was possible to evaluate 830 with respect to efficacy and side-effects. In most cases a dosage of 400 mg X 2 was used but in severe cases 800 mg X 2 was used. The clinical outcome was assessed as good for 79% of the patients, while 17% showed an improvement and 3% a failure. The tolerance was good with an over-all incidence of 8% side-effects, of which dyspepsia was the most common.


Subject(s)
Ampicillin/analogs & derivatives , Respiratory Tract Infections/drug therapy , Ampicillin/administration & dosage , Ampicillin/adverse effects , Ampicillin/therapeutic use , Belgium , Bronchitis/drug therapy , Bronchopneumonia/drug therapy , Clinical Trials as Topic , Drug Eruptions/etiology , Drug Tolerance , Dyspepsia/chemically induced , Family Practice , Humans , Otitis Media/drug therapy , Tonsillitis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...